Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (481-490 of 529) with videos related to

Pageof 53
Sort By:
Nature|August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)Flor M Munoz, Christine M Posavad, Barbra A Richardson, et al.
The Journal of Infectious Diseases|November 29, 2023
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In VivoAzra Blazevic, Rachel L Edwards, Mei Xia, et al.
JAMA|October 2, 2008
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trialNina Marano, Brian D Plikaytis, Stacey W Martin, et al.
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
The New England Journal of Medicine|October 14, 2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy StudyEdward E Walsh, Robert Frenck, Ann R Falsey, et al.
Nature|December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccinationRama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.
Cell|May 16, 2017
Metabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L Sullivan, Nadine Rouphael, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
Pageof 53

Showing results (481-490 of 529) with videos related to

Sort By:
Pageof 53
Nature|August 14, 2020
Phase I/II study of COVID-19 RNA vaccine BNT162b1 in adultsMark J Mulligan, Kirsten E Lyke, Nicholas Kitchin, et al.
Medrxiv : the Preprint Server for Health Sciences|June 23, 2022
COVID-19 booster vaccination during pregnancy enhances maternal binding and neutralizing antibody responses and transplacental antibody transfer to the newborn (DMID 21-0004)Flor M Munoz, Christine M Posavad, Barbra A Richardson, et al.
The Journal of Infectious Diseases|November 29, 2023
Phase 1 Open-Label Dose Escalation Trial for the Development of a Human Bacillus Calmette-Guérin Challenge Model for Assessment of Tuberculosis Immunity In VivoAzra Blazevic, Rachel L Edwards, Mei Xia, et al.
JAMA|October 2, 2008
Effects of a reduced dose schedule and intramuscular administration of anthrax vaccine adsorbed on immunogenicity and safety at 7 months: a randomized trialNina Marano, Brian D Plikaytis, Stacey W Martin, et al.
Journal of Virology|August 23, 2019
Fc Gamma Receptor Polymorphisms Modulated the Vaccine Effect on HIV-1 Risk in the HVTN 505 HIV Vaccine TrialShuying S Li, Peter B Gilbert, Lindsay N Carpp, et al.
The New England Journal of Medicine|October 14, 2020
Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesEdward E Walsh, Robert W Frenck, Ann R Falsey, et al.
Medrxiv : the Preprint Server for Health Sciences|August 26, 2020
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy StudyEdward E Walsh, Robert Frenck, Ann R Falsey, et al.
Nature|December 14, 2017
Origin and differentiation of human memory CD8 T cells after vaccinationRama S Akondy, Mark Fitch, Srilatha Edupuganti, et al.
Cell|May 16, 2017
Metabolic Phenotypes of Response to Vaccination in HumansShuzhao Li, Nicole L Sullivan, Nadine Rouphael, et al.
Annals of the Rheumatic Diseases|May 26, 2021
Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory diseaseRebecca H Haberman, Ramin Herati, David Simon, et al.
Pageof 53